Meeder Asset Management Inc Spring Works Therapeutics, Inc. Transaction History

Meeder Asset Management Inc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 11, 2022	SELL	$53.3 - $75.84 $66,891 - $95,179	-1,255 Closed	0 $0
Q3 2021 Nov 08, 2021	BUY	$62.66 - $88.26 $3,947 - $5,560	63 Added 5.29%	1,255 $80,000
Q2 2021 Aug 09, 2021	SELL	$67.45 - $85.63 $35,074 - $44,527	-520 Reduced 30.37%	1,192 $98,000
Q1 2021 Apr 28, 2021	BUY	$65.1 - $93.59 $111,451 - $160,226	1,712 New	1,712 $127,000
Q4 2020 Feb 09, 2021	SELL	$48.36 - $77.92 $18,570 - $29,921	-384 Closed	0 $0
Q3 2020 Nov 02, 2020	BUY	$36.14 - $51.99 $13,877 - $19,964	384 New	384 $17,000

238

68.9M

144K

257K

Ticker SWTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,401,100
Market Cap $2.28B
Description
SpringWorks Therapeutics, Inc. acquires, develops, and commercializes medicines for underserved patient populations suffering from rare diseases and cancer. Its lead product candidate is nirogacestat, an oral small molecule gamma secretase inhibitor that is in Phase III clinical trial for the treatment of desmoid tumors. The company is also deve...

Get notified when there are updates to the investment portfolio of Meeder Asset Management Inc, based on Form 13F filings with the SEC.

Stay updated on Meeder Asset Management Inc with notifications on news.